AstraZeneca expanding pain control centre in Montreal

February 26, 2007

AstraZeneca Canada Inc is investing $10 million in an expansion of its pain control research centre in Montreal. The $300-million centre opened in 1997 in the Saint-Laurent Technoparc by then Astra Pharma Inc and was the company's first major R&D facility outside of its home base in Sweden (R$, May 28/97). It employs 125 scientists and is one three basic pharmaceutical research centres in Canada. Since its inception it has discovered six promising compounds. The firm says the 1,000 sq-m expansion and new equipment will facilitate the transfer of chemists from a nearby site and provide room for future growth....


Other stories mentioning these organizations, people and topics
Organizations:

Other News






Events For Leaders in
Science, Tech, Innovation, and Policy


Discuss and learn from those in the know at our virtual and in-person events.



See Upcoming Events










You have 1 free article remaining.
Don't miss out - start your free trial today.

Start your FREE trial    Already a member? Log in






Top

By using this website, you agree to our use of cookies. We use cookies to provide you with a great experience and to help our website run effectively in accordance with our Privacy Policy and Terms of Service.